These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 24758626)

  • 1. A trial of mass isoniazid preventive therapy for tuberculosis control.
    Churchyard GJ; Fielding KL; Grant AD
    N Engl J Med; 2014 Apr; 370(17):1662-3. PubMed ID: 24758626
    [No Abstract]   [Full Text] [Related]  

  • 2. A trial of mass isoniazid preventive therapy for tuberculosis control.
    Richardson ET; Wood R
    N Engl J Med; 2014 Apr; 370(17):1661-2. PubMed ID: 24758628
    [No Abstract]   [Full Text] [Related]  

  • 3. A trial of mass isoniazid preventive therapy for tuberculosis control.
    Ukwaja KN; Abimbola S
    N Engl J Med; 2014 Apr; 370(17):1661. PubMed ID: 24758627
    [No Abstract]   [Full Text] [Related]  

  • 4. Effectiveness of tuberculosis preventive therapy in gold miners.
    Yaqub F
    Lancet Respir Med; 2014 Mar; 2(3):181. PubMed ID: 24745052
    [No Abstract]   [Full Text] [Related]  

  • 5. Troubles with tuberculosis prevention.
    Rubin EJ
    N Engl J Med; 2014 Jan; 370(4):375-6. PubMed ID: 24450896
    [No Abstract]   [Full Text] [Related]  

  • 6. Tuberculosis control in South African gold mines: mathematical modeling of a trial of community-wide isoniazid preventive therapy.
    Vynnycky E; Sumner T; Fielding KL; Lewis JJ; Cox AP; Hayes RJ; Corbett EL; Churchyard GJ; Grant AD; White RG
    Am J Epidemiol; 2015 Apr; 181(8):619-32. PubMed ID: 25792607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A trial of mass isoniazid preventive therapy for tuberculosis control.
    Churchyard GJ; Fielding KL; Lewis JJ; Coetzee L; Corbett EL; Godfrey-Faussett P; Hayes RJ; Chaisson RE; Grant AD;
    N Engl J Med; 2014 Jan; 370(4):301-10. PubMed ID: 24450889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of routine isoniazid preventive therapy on tuberculosis incidence among HIV-infected men in South Africa: a novel randomized incremental recruitment study.
    Grant AD; Charalambous S; Fielding KL; Day JH; Corbett EL; Chaisson RE; De Cock KM; Hayes RJ; Churchyard GJ
    JAMA; 2005 Jun; 293(22):2719-25. PubMed ID: 15941800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isoniazid preventive therapy.
    Salpeter SR
    Arch Intern Med; 1996 Apr; 156(7):811. PubMed ID: 8615716
    [No Abstract]   [Full Text] [Related]  

  • 10. Benefits of isoniazid preventive therapy.
    Rose DN
    Arch Intern Med; 1996 Mar; 156(6):684-5. PubMed ID: 8629883
    [No Abstract]   [Full Text] [Related]  

  • 11. A new tool for monitoring isoniazid preventive therapy.
    Eisenhut M
    Int J Tuberc Lung Dis; 2013 Mar; 17(3):424. PubMed ID: 23407235
    [No Abstract]   [Full Text] [Related]  

  • 12. Empirical tuberculosis therapy versus isoniazid in adult outpatients with advanced HIV initiating antiretroviral therapy (REMEMBER): a multicountry open-label randomised controlled trial.
    Hosseinipour MC; Bisson GP; Miyahara S; Sun X; Moses A; Riviere C; Kirui FK; Badal-Faesen S; Lagat D; Nyirenda M; Naidoo K; Hakim J; Mugyenyi P; Henostroza G; Leger PD; Lama JR; Mohapi L; Alave J; Mave V; Veloso VG; Pillay S; Kumarasamy N; Bao J; Hogg E; Jones L; Zolopa A; Kumwenda J; Gupta A;
    Lancet; 2016 Mar; 387(10024):1198-209. PubMed ID: 27025337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of improved tuberculosis screening and isoniazid preventive therapy on incidence of tuberculosis and death in patients with HIV in clinics in Rio de Janeiro, Brazil: a stepped wedge, cluster-randomised trial.
    Durovni B; Saraceni V; Moulton LH; Pacheco AG; Cavalcante SC; King BS; Cohn S; Efron A; Chaisson RE; Golub JE
    Lancet Infect Dis; 2013 Oct; 13(10):852-8. PubMed ID: 23954450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erring on the side of action: time for HIV programmes to implement isoniazid preventive therapy.
    Granich R; Getahun H; Reid A; Raviglione M; De Cock KM
    Int J Tuberc Lung Dis; 2009 Aug; 13(8):925-6. PubMed ID: 19723370
    [No Abstract]   [Full Text] [Related]  

  • 15. Short-course untargeted isoniazid preventive therapy in South Africa: time to rethink policy?
    Lawn SD; Wood R
    Int J Tuberc Lung Dis; 2012 Aug; 16(8):995-6. PubMed ID: 22762421
    [No Abstract]   [Full Text] [Related]  

  • 16. Tuberculosis screening and isoniazid preventive therapy implementation: a Brazilian experience.
    Swaminathan S; Chandrasekaran P
    Expert Rev Anti Infect Ther; 2014 Mar; 12(3):289-92. PubMed ID: 24455973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isoniazid preventive therapy for HIV-infected people: evidence to support implementation.
    Eldred LJ; Churchyard G; Durovni B; Godfrey-Faussett P; Grant AD; Getahun H; Chaisson RE
    AIDS; 2010 Nov; 24 Suppl 5():S1-3. PubMed ID: 21079422
    [No Abstract]   [Full Text] [Related]  

  • 18. Implementation of isoniazid preventive therapy for HIV-infected adults: overstatement of district reports.
    Martinson NA; McLeod KE; Milovanovic M; Msandiwa R; Lebina L
    Int J Tuberc Lung Dis; 2014 Aug; 18(8):1005. PubMed ID: 25199022
    [No Abstract]   [Full Text] [Related]  

  • 19. The impact of isoniazid preventive therapy and antiretroviral therapy on tuberculosis in children infected with HIV in a high tuberculosis incidence setting.
    Frigati LJ; Kranzer K; Cotton MF; Schaaf HS; Lombard CJ; Zar HJ
    Thorax; 2011 Jun; 66(6):496-501. PubMed ID: 21460373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isoniazid prevention of HIV-associated tuberculosis.
    Rangaka MX; Wilkinson RJ
    Lancet Infect Dis; 2013 Oct; 13(10):825-7. PubMed ID: 23954451
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.